Clinical Trials Logo
  1. Home
  2. Total Shoulder Arthroplasty
  3. NCT06143306

Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement

Total Shoulder Arthroplasty Clinical Trial

Official title:
Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement

Clinical Trial Summary

The use of ISB in patients undergoing total shoulder arthroplasty (TSA) is the gold standard and results in significantly reduced pain scores and opioid use. However, patients still have pain and the majority require opioids postoperatively as the interscalene block (ISB) doesn't cover all of the dermatomes impacted during TSA. A pectoserratus block typically provides coverage to additional dermatomes that are impacted during TSA. Currently ISB is performed for every patient and perform a pectoserratus block to a portion of our patients undergoing TSA. The purpose of the study is to determine if the addition of the pectoserratus block to the ISB will results in improvement in pain control and decrease in opioid use, among patients undergoing TSA. This is a randomized prospective controlled trial. All patients undergoing total shoulder arthroplasty or reverse total shoulder arthroplasty aged 18-85 will be considered eligible for the study. Participants will be randomized to one of 2 treatment groups. Group 1 will receive an ultrasound guided pectoserratus block with 25 mL of 0.25% bupivacaine. Group 2 will be the control and receive an ultrasound guided pectoserratus block with 25 mL of saline. The drug will be administered by the anesthesiologist in-charge of the participant's care or an anesthesiologist who is a part of the study team.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06143306
Study type Interventional
Source University of Minnesota
Contact Candace Nelson
Phone 612-625-7116
Email nelso377@umn.edu
Status Recruiting
Phase Phase 4
Start date March 20, 2024
Completion date May 1, 2027
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05900427 - Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients Phase 4
Completed NCT01430468 - Patient Specific Instruments Versus Standard Surgical Instruments N/A
Completed NCT03730597 - Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study N/A
Completed NCT01782872 - Analgesia After Total Shoulder Arthroplasty Phase 4
Completed NCT06109415 - A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Phase 4
Active, not recruiting NCT03623269 - Posterior Approach to Total Shoulder Arthroplasty
Terminated NCT03219983 - Pain Management After Total Shoulder Arthroplasty Phase 4
Completed NCT01726972 - A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
Enrolling by invitation NCT06133933 - Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption
Suspended NCT04416932 - Ultrasound After Total Shoulder Arthroplasty
Completed NCT04855019 - Post Surgical Pain in Arthroscopic Shoulder N/A
Completed NCT03887650 - LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs Phase 4
Recruiting NCT05068960 - Postoperative Pain Control in Total Shoulder Arthroplasty Phase 4
Active, not recruiting NCT02143245 - Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections N/A
Completed NCT01550952 - Interscalene Dynamometer Pilot Study N/A
Completed NCT03969875 - Comparison of Analgesic Efficacy Between of Interscalene Block With Liposomal Bupivacaine With Bupivacaine and Dexamethasone
Completed NCT04364867 - Exparel for Total Shoulder Arthroplasty Phase 4